Kayne Anderson Rudnick Investment Management LLC Sells 131,046 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Kayne Anderson Rudnick Investment Management LLC lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 9.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,192,832 shares of the company’s stock after selling 131,046 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 7.92% of U.S. Physical Therapy worth $110,242,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of USPH. Silvercrest Asset Management Group LLC purchased a new stake in U.S. Physical Therapy in the first quarter valued at approximately $8,158,000. Harbor Capital Advisors Inc. raised its position in shares of U.S. Physical Therapy by 292.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock valued at $701,000 after buying an additional 5,652 shares in the last quarter. Southernsun Asset Management LLC lifted its holdings in shares of U.S. Physical Therapy by 5.9% during the 4th quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock worth $44,634,000 after acquiring an additional 26,758 shares during the last quarter. Norden Group LLC grew its position in U.S. Physical Therapy by 1,841.6% in the first quarter. Norden Group LLC now owns 63,938 shares of the company’s stock worth $7,217,000 after acquiring an additional 60,645 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in U.S. Physical Therapy by 1.0% in the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after acquiring an additional 10,175 shares during the last quarter.

U.S. Physical Therapy Trading Down 2.1 %

NYSE USPH opened at $83.27 on Friday. The stock has a 50-day moving average of $88.60 and a 200-day moving average of $97.08. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $113.63. The firm has a market cap of $1.26 billion, a PE ratio of 67.70, a price-to-earnings-growth ratio of 4.11 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same period last year, the company posted $0.76 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date was Friday, August 23rd. U.S. Physical Therapy’s payout ratio is 143.09%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Barrington Research reissued an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research note on Friday.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at approximately $580,635. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.